Home/Investors/Founders

Founders

Biotech Investor · 7 portfolio companies

Portfolio

7

Combined Value

$15.9M

Focus Areas

17

Top Stage

Pre-clinical

Investment Focus

Oncology Critical Care Infectious Disease Dermatology Gastroenterology Women's Health Major Depressive Disorder Treatment-Resistant Depression Spinal Cord Injury Traumatic Brain Injury Urology Neurology Ophthalmology Glaucoma Retinal Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Citius Pharmaceuticals	Approved	$15.9M	Oncology, Critical Care
CrossBay Medical	Commercial	—	Women's Health
Mapreg	Phase 2	—	Major Depressive Disorder, Treatment-Resistant Depression
OmniCyte	Pre-clinical	—	Oncology
Dignify Therapeutics	Pre-clinical	—	Urology, Gastroenterology
Amorphex Therapeutics	Pre-clinical	—	Ophthalmology, Glaucoma
Neuronasal	Pre-clinical	—	Neurology, Traumatology

Frequent Co-Investors

Institutional investors1 shared RA Capital Management1 shared Management1 shared Business Angels/Family Offices1 shared GENERALI FR (main shareholder)1 shared Angel investors1 shared Connecticut Innovations1 shared North Carolina Biotechnology Center1 shared